Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Josephine Egan
Role and Development of GLP-1 Receptor Agonists in the Management of Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Related publications
The Cardiovascular Effects of GLP-1 Receptor Agonists
Cardiovascular Therapeutics
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Selecting GLP-1 Agonists in the Management of Type 2 Diabetes: Differential Pharmacology and Therapeutic Benefits of Liraglutide and Exenatide
Therapeutics and Clinical Risk Management
Β-Arrestin-Biased Agonists of the GLP-1 Receptor From Β-Amino Acid Residue Incorporation Into GLP-1 Analogues
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
Pdb68 - Cost-Effectiveness Analysis of Exenatide Versus GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Extra Glycemic Impacts of GLP-1 Receptor Agonists: Benefits of a Class Effect?
Open Journal of Endocrine and Metabolic Diseases
SGLT2 Inhibitors or GLP-1 Receptor Agonists as Second-Line Therapy in Type 2 Diabetes: Patient Selection and Perspectives
Vascular Health and Risk Management
Evaluating Preferences for Profiles of GLP-1 Receptor Agonists Among Injection-Naïve Type 2 Diabetes Patients in the UK
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Primary-Care Observational Database Study of the Efficacy of GLP-1 Receptor Agonists and Insulin in the UK
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes